Wall Street Market Report
|London | Wall Street | Asia|
(Open): Merger prospects and banking results paved the way for a moderate rise in stocks early on Monday.
Citigroup's second quarter results were better than anticipated, and the bank confirmed it will pay $7bn (£4bn) to settle charges it misled investors.
Two mergers are on the cards in the pharmaceutical sector.
Pharmaceuticals manufacturer, Mylan saw its shares rise 2.45% after it announced it was buying part of the generic-drugs division of Abbott Laboratories' in a deal worth $5.3bn (£3bn). Abbott's shares rose 0.25% in New York.
The Citigroup settlement stems from the sale of securities made up of sub-prime mortgages, which were at the centre of the 2008 financial crisis. The bank's shares were up 3.6%.
Citigroup is the second major bank to pay a settlement since an investigation into the loans.